UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tacrolimus Dose Requirements and CYP3A5 Genotype and the Development of Calcineurin Inhibitor-Associated Nephrotoxicity in Renal Allograft Recipients

Therapeutic drug monitoring, 2010-08, Vol.32 (4), p.394-404

2010

Volltextzugriff (PDF)

Diagnosis and prevention of chronic kidney allograft loss

The Lancet (British edition), 2011, Vol.378 (9800), p.1428-1437

2011

Volltextzugriff (PDF)

Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients

Transplantation, 2006-10, Vol.82 (8), p.1074-1084

2006

Volltextzugriff (PDF)

Impact of POR28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients

Therapeutic drug monitoring, 2014-02, Vol.36 (1), p.71-79

2014

Volltextzugriff (PDF)

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-07, Vol.330 (1), p.33

2023

Volltextzugriff (PDF)

Calcineurin Inhibitor Nephrotoxicity

Clinical journal of the American Society of Nephrology, 2009-02, Vol.4 (2), p.481-508

2009

Volltextzugriff (PDF)

Clinical determinants of calcineurin inhibitor disposition: a mechanistic review

Drug metabolism reviews, 2016-01, Vol.48 (1), p.88-112

2016

Volltextzugriff (PDF)

The histology of kidney transplant failure: a long-term follow-up study

Transplantation, 2014-08, Vol.98 (4), p.427-435

2014

Volltextzugriff (PDF)

Management of polyomavirus-associated nephropathy in renal transplant recipients

Nature reviews. Nephrology, 2012-07, Vol.8 (7), p.390-402

Kuypers, Dirk R J

2012

Volltextzugriff (PDF)

Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report

American journal of kidney diseases, 2023-03, Vol.81 (3), p.364-367

2023

Volltextzugriff (PDF)

Immunotherapy in Elderly Transplant Recipients: A Guide to Clinically Significant Drug Interactions

Drugs & aging, 2009-01, Vol.26 (9), p.715-737

Kuypers, Dirk R. J.

2009

Volltextzugriff (PDF)

Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical Outcome

Clinical pharmacology and therapeutics, 2020-02, Vol.107 (2), p.347-358

Kuypers, Dirk R.J.

2020

Volltextzugriff (PDF)

Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal Allografts

Journal of the American Society of Nephrology, 2009-11, Vol.20 (11), p.2468-2480

2009

Volltextzugriff (PDF)

The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide

Transplantation, 2007-08, Vol.84 (3), p.362-373

2007

Volltextzugriff (PDF)

New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation

Therapeutic drug monitoring, 2009-08, Vol.31 (4), p.416-435

2009

Volltextzugriff (PDF)

Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit

British journal of clinical pharmacology, 2015-09, Vol.80 (3), p.548-559

2015

Volltextzugriff (PDF)

Relationship between In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Systemic Tacrolimus Metabolite/Parent Drug Ratio in Renal Transplant Recipients and Healthy Volunteers

Drug metabolism and disposition, 2018-11, Vol.46 (11), p.1507-1513

2018

Volltextzugriff (PDF)

Cutaneous phaeohyphomycosis in renal allograft recipients: report of 2 cases and review of the literature

Diagnostic microbiology and infectious disease, 2010-10, Vol.68 (2), p.177-180

2010

Volltextzugriff (PDF)

The impact of uridine diphosphate–glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single‐nucleotide polymorphisms T—275A and C—2152T on early mycophenolic acid dose‐interval exposure in de novo renal allograft recipients

Clinical pharmacology and therapeutics, 2005-10, Vol.78 (4), p.351-361

2005

Volltextzugriff (PDF)

From Nonadherence to Adherence

Transplantation, 2020-07, Vol.104 (7), p.1330-1340

Kuypers, Dirk R J

2020

Volltextzugriff (PDF)

Clinical Efficacy and Toxicity Profile of Tacrolimus and Mycophenolic Acid in Relation to Combined Long-term Pharmacokinetics in de Novo Renal Allograft Recipients

Clinical pharmacology and therapeutics, 2004-05, Vol.75 (5), p.434-447

2004

Volltextzugriff (PDF)

Organ Transplantation 3: Diagnosis and prevention of chronic kidney allograft loss

The Lancet (British edition), 2011-10, Vol.378 (9800), p.1428

2011

Volltextzugriff (PDF)

Skin problems in chronic kidney disease

Nature clinical practice. Nephrology, 2009-03, Vol.5 (3), p.157-170

Kuypers, Dirk RJ

2009

Volltextzugriff (PDF)

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients

Pharmacogenetics and genomics, 2008-04, Vol.18 (4), p.339-348

2008

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Englisch
(139)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Life Sciences & Biomedicine
(109)
Humans
(107)
Male
(65)
Female
(64)
Kidney Transplantation
(59)
Transplantation
(57)
Middle Aged
(56)
Biological And Medical Sciences
(46)
Medical Sciences
(45)
Surgery
(38)
Adult
(37)
Pharmacology & Pharmacy
(34)
Immunosuppressive Agents - Therapeutic Use
(32)
Pharmacology. Drug Treatments
(30)
Prospective Studies
(28)
Urology & Nephrology
(28)
Aged
(27)
Tacrolimus
(27)
Graft Rejection - Prevention & Control
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tacrolimus Dose Requirements and CYP3A5 Genotype and the Development of Calcineurin Inhibitor-Associated Nephrotoxicity in Renal Allograft Recipients

Diagnosis and prevention of chronic kidney allograft loss

Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients

Impact of POR28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial

Calcineurin Inhibitor Nephrotoxicity

Clinical determinants of calcineurin inhibitor disposition: a mechanistic review

The histology of kidney transplant failure: a long-term follow-up study

Management of polyomavirus-associated nephropathy in renal transplant recipients

Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report

Immunotherapy in Elderly Transplant Recipients: A Guide to Clinically Significant Drug Interactions

Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical Outcome

Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal Allografts

A Machine Learning-Driven Virtual Biopsy System For Kidney Transplant Patients

The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide

New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation

Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit

Relationship between In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Systemic Tacrolimus Metabolite/Parent Drug Ratio in Renal Transplant Recipients and Healthy Volunteers

Cutaneous phaeohyphomycosis in renal allograft recipients: report of 2 cases and review of the literature

The impact of uridine diphosphate–glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single‐nucleotide polymorphisms T—275A and C—2152T on early mycophenolic acid dose‐interval exposure in de novo renal allograft recipients

From Nonadherence to Adherence

Clinical Efficacy and Toxicity Profile of Tacrolimus and Mycophenolic Acid in Relation to Combined Long-term Pharmacokinetics in de Novo Renal Allograft Recipients

Organ Transplantation 3: Diagnosis and prevention of chronic kidney allograft loss

Skin problems in chronic kidney disease

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients

Suchergebnisse filtern